// App-Quantinova.ai

Abstract 13296 : Bivalirudin versus Unfractioned Heparin in Patients With Diabetes Mellitus Undergoing Elective Percutaneous Coronary Intervention: Results at One Year

Researchers

Presenter

  • Yulong Li

Principal Investigators

  • Jiawen Li

  • Yuejin Yang

  • Jinqing Yuan

  • Xueyan Zhao

Medical Centers

  • Fuwai hospital, Beijing

  • Beijing

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Diabetes

  • Venous thrombosis

  • Stroke

Biomarkers

  • Glycosylphosphatidylinositol

Drug/Treatment

  • Bivalirudin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved